Diagnosing Nonsteroidal Anti-Inflammatory Drug–Hypersensitivity/Allergy and Nonsteroidal Anti-Inflammatory Drug–Exacerbated or Induced Food Allergy Phenotypes in Children and Adolescents
The Journal of Allergy and Clinical Immunology: In Practice · 2026
DOI: 10.1016/j.jaip.2026.06.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Rocco Luigi Valluzzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research in Pediatric Specialties Area, Division of Allergy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: …. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Food Hypersensitivity, Drug Hypersensitivity. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in children. Hypersensitivity reactions (HRs) to NSAIDs represent a diagnostic challenge, particularly because NSAIDs may act as aggravating factors or cofactors as in two phenotypes recently named NSAID-exacerbated food allergy (NEFA) and NSAID-induced food allergy (NIFA). OBJECTIVE: To diagnose NSAID hypersensitivity/allergy (NH/A) and NEFA/NIFA phenotypes in children and adolescents, classify HRs to NSAIDs according to updated international guidelines, and identify clinical and immunologic predictors of true NH/A. METHODS: We prospectively studied 336 children and adolescents with a history of HRs to NSAIDs, following international guidelines, which include challenges with the suspected NSAIDs. Primary outcomes were identification of NH/A phenotypes and their predictors. RESULTS: Hypersensitivity or allergy to NSADISs was diagnosed in 104 of 336 patients (31%). The most frequent phenotypes were single-NSAID-induced urticaria, angioedema, or anaphylaxis (55.8%) and NSAID-induced urticaria, angioedema, or anaphylaxis (22.1%). We excluded NH/A in 232 patients (69%), 48 of whom received the diagnosis of NEFA/NIFA. Sensitization to Pru p 3 was strongly associated with NEFA/NIFA. Non-hypersensitive or allergic reactions were associated with antipyretic use (odds ratio [OR] = 5.92; 95% CI, 3.60-9.72), urticaria (OR = 3.06; 95% CI, 1.77-5.28), and younger age (OR per 6-year increment = 0.64; 95% CI, 0.47-0.89). Internal validation showed good discrimination (area under the receiver operating characteristic curve, 0.82; cross-validated area under the receiver operating characteristic curve, 0.79). CONCLUSIONS: Approximately one third of children with suspected reactions had confirmed NH/A, whereas 14.3% had NEFA/NIFA. In 69% of patients, the NH/A label was removed. Many reactions during antipyretic use appear to be related to infection rather than true NSAID hypersensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research in Pediatric Specialties Area, Division of Allergy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: roccoluigi.valluzzi@opbg.net.
- Translational Research in Pediatric Specialties Area, Division of Allergy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, University of Rome Tor Vergata, Rome, Italy.
- Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.
- Department of Woman, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
- BIOS S.p.A. Società Benefit, Rome, Italy.
Förderung
- Ministero della Salute
Zitieren
APA
Valluzzi, R. L., Urbani, S., Sciannamea, M., Diakanthos, M., Carfora, F., Klain, A., Calandrelli, V., Dahdah, L., Fierro, V., Fiocchi, A., & Romano, A. G. (2026). Diagnosing Nonsteroidal Anti-Inflammatory Drug–Hypersensitivity/Allergy and Nonsteroidal Anti-Inflammatory Drug–Exacerbated or Induced Food Allergy Phenotypes in Children and Adolescents. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.06.044
Vancouver
Valluzzi RL, Urbani S, Sciannamea M, Diakanthos M, Carfora F, Klain A, et al. Diagnosing Nonsteroidal Anti-Inflammatory Drug–Hypersensitivity/Allergy and Nonsteroidal Anti-Inflammatory Drug–Exacerbated or Induced Food Allergy Phenotypes in Children and Adolescents. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.06.044
BibTeX
@article{Valluzzi2026,
author = {Valluzzi, Rocco Luigi and Urbani, Sara and Sciannamea, Maddalena and Diakanthos, Maria and Carfora, Francesca and Klain, Angela and Calandrelli, Veronica and Dahdah, Lamia and Fierro, Vincenzo and Fiocchi, Alessandro and Romano, Antonino Gaetano},
title = {Diagnosing Nonsteroidal Anti-Inflammatory Drug–Hypersensitivity/Allergy and Nonsteroidal Anti-Inflammatory Drug–Exacerbated or Induced Food Allergy Phenotypes in Children and Adolescents},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
doi = {10.1016/j.jaip.2026.06.044}
}
EUVIMED